Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Haber

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Cell|December 4, 2003
The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesisDaniel A Haber
Cancer Research|June 17, 2006
Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processingSven Diederichs, Daniel A Haber
Science (New York, N.Y.)|February 24, 2018
Cancer detection: Seeking signals in bloodMark Kalinich, Daniel A Haber
Cancer Research|May 23, 2015
Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer TherapyShyamala Maheswaran, Daniel A Haber
Cell|December 18, 2007
Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expressionSven Diederichs, Daniel A Haber
Breast Cancer Research : BCR|June 10, 2003
Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer riskJenny Varley, Daniel A Haber
Nature|March 9, 2007
Cancer: drivers and passengersDaniel A Haber, Jeff Settleman
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Overcoming acquired resistance to Iressa/Tarceva with inhibitors of a different classDaniel A Haber, Jeffrey Settleman
Nature|November 13, 2015
Cell fate: Transition loses its invasive edgeShyamala Maheswaran, Daniel A Haber
Current Opinion in Genetics & Development|January 15, 2010
Circulating tumor cells: a window into cancer biology and metastasisShyamala Maheswaran, Daniel A Haber
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Cell|December 4, 2003
The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesisDaniel A Haber
Cancer Research|June 17, 2006
Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processingSven Diederichs, Daniel A Haber
Science (New York, N.Y.)|February 24, 2018
Cancer detection: Seeking signals in bloodMark Kalinich, Daniel A Haber
Cancer Research|May 23, 2015
Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer TherapyShyamala Maheswaran, Daniel A Haber
Cell|December 18, 2007
Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expressionSven Diederichs, Daniel A Haber
Breast Cancer Research : BCR|June 10, 2003
Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer riskJenny Varley, Daniel A Haber
Nature|March 9, 2007
Cancer: drivers and passengersDaniel A Haber, Jeff Settleman
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Overcoming acquired resistance to Iressa/Tarceva with inhibitors of a different classDaniel A Haber, Jeffrey Settleman
Nature|November 13, 2015
Cell fate: Transition loses its invasive edgeShyamala Maheswaran, Daniel A Haber
Current Opinion in Genetics & Development|January 15, 2010
Circulating tumor cells: a window into cancer biology and metastasisShyamala Maheswaran, Daniel A Haber
Pageof 24